No Title Presenter
Prize Orals
Paul Brand Award Oral Novel plantar pressure-sensing smart insoles reduce foot ulcer incidence in 'high risk' diabetic patients: a longitudinal study Caroline Abbott, United Kingdom
Prize Oral 1 Bone marrow oedema of the navicular, intermediate cuneiform and 5th metatarsal is a significant predictor of sagittal plane deformity in acute Charcot osteoarthropathy  Maximilian deSancha, United Kingdom
Prize Oral 2 The use of autologous leucocyte, platelet and fibrin patches* in the management of hard-to-heal diabetic foot ulcers: a multicentre, multinational, observer-blinded, randomised controlled trial Frances Game, United Kingdom
Prize Oral 3 Data linkage and geospatial mapping exposes inequalities in outcomes for diabetic foot disease in Glasgow Joanne Hurst, United Kingdom

Oral Abstracts

OP01

Relationship between diabetic retinopathy and lower-extremity artery disease in subjects with type 2 diabetes   Kamel Mohammedi, France
OP02 Arterial disease below the ankle in the diabetic foot: The final fontier   Chris Manu, United Kingdom
OP03 Ultrasound versus sharp wound debridement in healing of recalcitrant neuropathic diabetic foot ulcers: clinical and pathological study   Fady Azmy Kyrillos, Egypt
OP04 An Update on Percutaneous Needle Tenotomy Treatment of Patients with Diabetes, Hammer, Mallet and Claw Toe Deformities   Jonas Hedegaard Andersen, Denmark
OP05 Outcome of endovascular first approach in diabetic asian patients with lower limb ischaemia    Alok Tiwari, United Kingdom
OP06 Reliability of a novel thermal imaging system for temperature assessment of feet   Wegin Tang, United Kingdom
OP07 Validation of a smartphone-based infrared thermal camera and its possibilities with 3D thermal mapping of diabetic foot ulcer detection.   R.F.M. van Doremalen, Netherlands
OP08 Does infrared thermography in addition to standard care reduce ulcer recurrence rate: data from a multi-centre single blind placebo controlled clinical trial   Nina Petrova, United Kingdom
OP09 Prognostic role of procalcitonin in patients with critical limb ischemia and diabetic foot infection   Marco Meloni, Italy
OP10 Correlation between decreased first metatarsophalangeal joint mobility in weigh bearing position and increased hallux plantar pressure   Mateo López Moral, Spain
OP11 Patients with diabetes mellitus with and without neuropathy exhibit disturbed midfoot energetics during walking   Giovanni Matricali, Belgium
OP12 The Importance of Evaluating Functional Hallux Limits in Patients at High-Risk of Hallux Ulceration    Raúl Molines Barroso, Spain
OP13 What kind of footwear do people at risk due to diabetic neuropathy wear?   Johana Venerová, Czech Republic
OP14 Ulcer Location and Probability of New Ulcers During Remission   Dirk Hochlenert, Germany
OP15 Lower-Extremity Amputation and Mortality in Diabetic and Non-Diabetic Patients with Necrotizing Fasciitis   Junho Ahn, United States
OP16 Diabetic foot osteomyelitis treatment: An audit of success rates in differing circumstances   Hannah Bond, United Kingdom
OP17 WBC-SPECT/CT to assess diabetic foot osteomyelitis remission: contribution of a Composite Severity Index   Julien Vouillarmet, France
OP18 The role of inflammatory markers on the time to healing in diabetic foot osteomyelitis treated by surgery or antibiotics   Aroa Tardáguila García, Spain
OP19 The use of locally delivered Highly Purified Calcium Sulphate impregnated with antibiotics in the management of the diabetic foot with osteomyelitis    Rajesh Jogia, United Kingdom
OP20 OSTEOMYELITIS SEQUESTRECTOMY AND APPLICATION OF AN ANTIBIOTIC-ELUTING BONE SUBSTITUTE TO AVOID MINOR AMPUTATION AND PRESERVE MECHANICAL STABILITY IN THE DIABETIC FOOT   Cristian Nicoletti, Italy
OP21 Factors Predicting Re-amputation  After Transmetatarsal Amputation in Patients with Diabetes Mellitus   Katherine Raspovic, United States
OP22 Risk of hospitalization for cardiovascular events or chronic kidney disease stratified by gender in patients with or without diabetic foot syndrome   elisabetta salutini, Italy
OP23 Heel ulcers differ largely for risk factors, treatment and outcome   Lena Rösgen, Germany
OP24 Differences between genders in outcomes of diabetic foot ulcer at one year follow-up   Cesare Miranda, Italy
OP25 The presence of chronic kidney disease in patients with diabetes foot disease is an independent risk factor for early mortality following major amputations - A retrospective study.   Victoria Milbourn, United Kingdom
OP26 Risk of Foot Ulcer Development in Patients with Diabetes - Relation to Isokinetic Muscle Strength, Sensory Function and Clinical Findings   Niels Ejskjaer, Denmark
OP27 Efficacy of sucrose-octasulfate dressing in neuro-ischaemic DFU considering factors influencing wound closure rate; a post-hoc analysis of the EXPLORER RCT   Ralf Lobmann, Germany
OP28 Non-neuronal control of proliferation and migration of keratinocytes on site of ulceration   Ekaterina Artemova, Russian Federation
OP29 Present international guidelines fail to classify 76% of infected diabetic feet which comes to minor amputation as severe.   Elizabeth Pendry, United Kingdom
OP30 Determinants of Diabetic Foot Self Care in Women with Diabetes: A Population-Based Study   Mahnaz Sanjari, Iran
OP31 Uncensored Incidence of Diabetic Foot Ulcers to Patients in Remission   Lawrence Lavery, United States
OP32 National incidence of foot disease-related amputations in people with and without diabetes in Australia, 2008-2015   Peter Lazzarini, Australia
OP33 The clinical path of the Diabetic Charcot Foot. An exploratory study.   Anne Rasmussen, Denmark
OP34 Temporary non-Regression of MRI bone marrow edema (edema equivalent signal changes) during treatment of active Charcot foot   Ernst Chantelau, Germany
OP35 Mortality and complications after treatment of acute Charcot foot - a longitudinal retrospective study over 19 years   Rasmus Jansen, Denmark
OP36 Patient Expectations prior to Charcot Reconstruction – Lessons from the 'Foot School'   Marcus Simmgen, United Kingdom
OP37 Detection of infection on Charcot foot: role of labeled leucocyte scan   Stamata Georga, Greece
OP38 The role of quantitative bone scan parameters for diagnosis of Charcot foot   Robert Bem, Czech Republic

Poster Abstracts

P001

External fixation in the management of infected Charcot foot, 6-month follow-up results   Veronika Woskova, Czech Republic
P002 Does the establishment of multidisciplinary diabetic foot team influence diabetes-related amputations?   Ieva Baikstiene, Lithuania
P003 Large-scale Retrospective Cohort Study of Post-operative Complications Following Ankle Fracture Surgery in Patients with Diabetes Mellitus   George Liu, United States
P004 Impact of foot infection on the outcomes of cell therapy in diabetic patients with no-option critical limb ischemia   Michal Dubsky, Czech Republic
P005 Incidence and clinical outcomes of new onset diabetic foot ulceration after transplantation   Angelica Sharma, United Kingdom
P006 Outcome of deep heel lesions in diabetic patients: the real world    Roberto da Ros, Italy
P007 Presence, Characterisation and Clinical impact of Anaemia in Diabetic Foot Ulceration: A cross sectional study with longitudinal follow up of DFU outcomes in a tertiary care setting   Matthew Anson, United Kingdom
P008 More than 50% of active, high-risk diabetic foot patients are unaware of their foot risk status and why they are referred to a multidisciplinary foot team    Daina Walton, United Kingdom
P009 There is nothing 'minor' about minor diabetic foot amputation.   Joanne Casey, United Kingdom
P010 The foot and the kidney: Is there a relation between chronic kidney disease and diabetic foot ulcer, and does chronic kidney disease affect the outcome of the ulcer?      Catya Franssen, Belgium
P011 Diabetes mellitus and Charcot neuro-osteoarthropathy (CNA): retrospective analysis and identification of predictive factors.   Elisabetta Iacopi, Italy
P012 The associated mortality on presentation with an acute Charcot foot    Erika Vainieri, United Kingdom
P013 A Retrospective Study of Patients with Charcot Neuropathic Osteopathy   Lena Soender Snogdal, Denmark
P014 The Charcot foot and mortality from 2000 to 2016   Susanne Engberg, Denmark
P015 Recombinant Type 1 Human Collagen from Tobacco Plant is Safe and Effective in Promoting and Sustaining Wound Repair in Diabetic Foot (DF) Post-surgical Lesions.   Elisabetta Iacopi, Italy
P016 Healing Chronic Diabetic Foot Ulcers with Cyclical Pressurized Topical Wound Oxygen Therapy: Expanded results from the TWO2 multi-national, multi-center, randomized, double blinded, placebo controlled trial   Michalel Edmonds, United Kingdom
P017 Use of Larval debridement therapy in the management of multiple infected diabetic foot ulcers – preventing amputation   Edward Jude, United Kingdom
P018 Cold Atmospheric Pressure Plasma as a Novel Treatment Modality in Diabetic Foot Ulcers: a Pilot Study.   Rimke Lagrand, Netherlands
P019 Autologous Mononuclear versus Mesenchymal Stem cells in healing of recalcitrant neuropathic diabetic foot ulcers   Ahmed Albehairy, Egypt
P020 IMPACT OF COMBINED TREATMENT WITH PATCH APPLICATION AND AEROSOL MIXTURE OF BIO-PROTECTIVE AND REGENERATIVE BIOCHEMICAL AGENTS (KAOLIN,SODIUM HYALURONATE,SILICON AND TITANIUM DIOXIDE NANOCRYSTALS), VERSUS PATCH MONOTHERAPY, IN THE PREVENTION AND TREATMENT OF THE DIABETIC FOOT ULCER.   Eleni Matopoulou, Greece
P021 Risk factors associated with unplanned above knee amputation after  transtibial amputation during the perioperative period   Dane Wukich, United States
P022 Drastic reduction in lower limb amputation rates in a European island state   Ruth Scicluna, Malta
P023 Predictors of further intervention after toe amputation in diabetic patients   Jamal Hoballah, Lebanon
P024 Long-term prognosis of patients with diabetic foot disease in Tanzania: amputation, sepsis and death over the course of two decades   Zulfiqarali G. Abbas, Tanzania
P025 Chopart amputation with subtalar joint arthrodesis at the same time are the effective method of prevention of foot deformity   Yuta Terabe, Japan
P026 Mortality Rates in Diabetics undergoing major lower limb amputation, in a small island state.    Francesca Theuma, Malta
P028 Reconstruction of severe atherosclerotic and obstructive diabetic feet using thoracodorsal artery perforator flaps with long vascular pedicle   Sang Wha Kim, Korea, Rep. of South
P029 Analysis of post-surgical complications after metatarsal head resection performing by plantar or dorsal approach   Esther Garcia Morales, Spain
P030 Reconstruction of diabetic lower leg and foot soft tissue defects using thoracodorsal artery perforator chimeric flaps   Youn Hwan Kim, Korea, Rep. of South
P031 Characteristics, management and outcome of patients with diabetic foot hospitalized in a tertiary referral hospital   STAVROULA-PANAGIOTA LONTOU, Greece
P032 Prevalence of foot pathology among the patients of Out-Patient Diabetes Clinic Ljubljana   Vilma Urbancic-Rovan, Slovenia
P033 A Prompt Surgical Management of Necrotizing Fasciitis in Diabetic Foot (DF) Patients Saves Limbs and Lives   Chiara Goretti, Italy
P034 Local delivery of antibiotics via highly purified calcium sulphate beads as an adjunct to surgical debridement in the acute management of diabetic foot osteomyelitis   Michael Pierides, United Kingdom
P035 Severe Diabetic Foot Infection and Osteomyelitis can be Successfully Treated with Outpatient Parenteral Antimicrobial Therapy   Satyan Rajbhandari, United Kingdom
P036 Infections among patients with a diabetic foot attack in UZ Leuven: antibiotic strategy and responsible germs   Toon Vissers, Belgium
P037 Review of Incidence of Adverse Effects in Patients Prescribed Linezolid for Diabetic Foot Infections   julie fosbrook, United Kingdom
P039 A retrospectieve study to review the incidence of Clostridium Difficile in diabetic foot ulcer patients who have been prescribed Co-amoxiclav Clindamycin Cephalosporins and Ciprofloxacin   Krishna Gohil, United Kingdom
P040 First Consult at Diabetic Foot Unit: What (bacteria) brings you in today?   Diana Duarte, Portugal
P041 The changing bacteriology of diabetic minor amputation   Samuel Galea, Malta
P042 RICK CLASSES AND THEIR TREATMENT IN EVERYDAY TEAM WORK   Fabrizia Toscanella, Italy
P044 How to successfully identify multidisciplinary units for prevention and diabetic foot care in France ?   Julien Vouillarmet, France
P045 Development of MyFootCare: a smartphone application to actively engage people in their diabetic foot ulcer self-care   Jaap van Netten, Netherlands
P046 Does integrated foot care really matter?   Matilde Monteiro-Soares, Portugal
P049 AID concept for multidisciplinary treatment of diabetic foot ulcers   Shinobu Ayabe, Japan
P050 The Integral Role of the Diabetic Foot Clinical Nurse Specialist in the Multidisciplinary Foot Team   Ian Alenjandro, United Kingdom
P051 Does attendance to a diabetic foot clinic result in improved glycaemic control with or without direct focus on glycaemic control?   Alexandros-Leonidas Liarakos, United Kingdom
P052 Adoption of IWGDF Guidance on Prevention and Management of Foot Problems in Diabetes for Iranian Version   Neda Mehrdad, Iran
P053 The Benefits of the Wound Assessement Tool by Photographic Images in the Early Diagnosis in Diabetic Foot Infection   Irene Sanz, Spain
P054 Bedside transcutaneous bone biopsy for diagnosing diabetic foot osteomyelitis: a feasibility study   Olga-Anna Kosmopoulou, Belgium
P055 Candida Albicans osteomyelitis in patient with type 2 diabetes   Vasiliki Mamakou, Greece
P056 RADIOLOGICAL AND CLINICAL OUTCOMES IN THE MEDIUM-TERM OF THE USE OF AN ANTIBIOTIC BONE SUBSTITUTE IN THE DIABETIC FOOT.    Christine Whisstock, Italy
P057 Evaluation: Local delivery of antibiotics in elective surgery to cure chronic diabetic foot osteomyelitis and its value to antibiotic stewardship.   Paula Grannon, United Kingdom
P058 Multidrug resistant bacteria increase risk of minor amputations and delay of postsurgical wound's healing in diabetic foot patients   Tatiana Zelenina, Russian Federation
P059 Temocillin: a useful addition to the antibiotic armoury for diabetic foot infection?   Naomi Fleming, United Kingdom
P060 Outcome of diabetic foot ulcer with osteomyelitis in Egypt   Ahmed Albehairy, Egypt
P061 Management of severe infection of diabetic foot in a low resource environment   Adalberto Silva, Portugal
P062 A retrospective study to determine how common Teicoplanin-induced Thrombocyctopaenia really is, in patients with diabetic foot disease   Jacqueline Mildred, United Kingdom
P063 PERIPHERAL NEUROPATHY IN PATIENTS WITH SARCOPENIA AND TYPE 2 DIABETES MELLITUS   Julia Onuchina, Russian Federation
P064 VIBRATIP: EVALUATION OF TWO EXAMINATION PROTOCOLS AGAINST TWO THRESHOLDS OF CLINICAL POLYNEUROPATHY IN TYPE 2 DIABETES MELLITUS   Nikolaos Papanas, Greece
P065 Baseline Vibration Perception Threshold does not Affect Response to First Line Treatment in Painful Diabetic Neuropathy   Satyan Rajbhandari, United Kingdom
P066 Early diagnosis of diabetic neuropathy using a quantitative sensory testing device (A pilot study)   Francisco Javier Alvaro Afonso, Spain
P067 Application of the frequency rhythmic electrical modulation system (FREMS-therapy) in treatment of neuropathic pain in patients with diabetic neuropathy.   Ekaterina Zaitseva, Russian Federation
P068 EVALUATION OF THE RELATION BETWEEN GLYCATED ALBUMIN AND PERIPHERAL DIABETIC NEUROPATHY   MONA MOHAMED ABDELSALAM, Egypt
P070 Impact of the serum level of trace elements on symptoms of peripheral neuropathy in type 2 diabetes   Rania Bahriz, Egypt
P071 Transcutaneous oxygen pressure - a suitable parameter for assessing the effect of autologous cell therapy in patients with ischemic diabetic foot   Andrea Nemcova, Czech Republic
P072 Role of thermal imaging for diagnostic assessment of acute charcot foot. A case series.   David Coppini, United Kingdom
P073 The use of thermography for the detection of diabetic foot complications   Cynthia Formosa, Malta
P074 Assessment of patients' needs and prototype development regarding custom-made diabetic footwear for home use   Tessa Busch-Westbroek, Netherlands
P075 Maximizing compliance to mid-term offloading in outpatients with recurrent diabetic foot ulcers: tolerability and efficacy of orthotic insoles   Giovanni Boschetti, Italy
P076 Attitudes and attributes of women and men using therapeutic shoes   John Alnemo, Sweden
P077 Flexor tenotomy in the treatment of toe ulcers: a feasibility study   Stokman Liesbeth, Belgium
P078 An innovative sealed therapeutic shoe to off-load and heal diabetic forefoot ulcers   Gustav Jarl, Sweden
P079 Real Life Experience of VACOped Boots in the Management of Diabetic Foot Ulcers    Wee Teck Lim, 
P080 the effect of percutaneous flexor tenotomy on healing and prevention of foot ulcers in patient with claw toe deformity.   Luuk Smeets, Netherlands
P082 Examination of diabetic foot by podiatrists in primary sector   Alima Ashraf, Denmark
P084 Telemedicine and home-monitoring applications for the diabetic foot: a systematic review   Wouter aan de Stegge, Netherlands
P085 A Systematic Review to determine the effectiveness of Motivational Interviewing as an intervention to improve adherence behaviours for the prevention of diabetic foot ulceration.   Jodi Binning, United Kingdom
P086 People with diabetes are interested in education on foot health self-management   Jarmila Jirkovska, Czech Republic
P087 Diabetic Foot Self Care Knowledge and Practice in Women with Diabetes   Mohammad Reza Amini, Iran
P088 PHYSICAL ACTIVITY AND ITS RELATIONSHIP TO THE PSYCHOLOGICAL STATUS IN PATIENTS WITH THE DIABETIC FOOT   Eliška Vrátná, Czech Republic
P089 The risk of deep vein thrombosis in patients seen in our multi-disciplinary diabetic foot clinic.   Shailesh Gohil, United Kingdom
P090 The occurence of Obstructive Sleep Apnea Syndrome in patients with diabetic foot and it´s possible association with limb ischemia and wound healing   Vladimira Fejfarova, Czech Republic
P091 Diabetic foot and cutaneous T-cell lymphoma: a clinical case   Liliana Fonseca, Portugal
P092 Diabetic neuropathy is a risk factor of chronic venous insufficiency   Pavlina Pithova, Czech Republic
P093 Independent correlations between the presence of retinopathy and kidney disease in diabetes and measures of both metabolic control and neuropathy   Dragan Tesic, Serbia
P094 Factors Contributing To Increased Hospital Length Of Stay For Diabetic Foot Patients    Chris Manu, United Kingdom
P095 Ulcers of the ankle are part of the DFS   Anna Katharina Trocha, Germany
P097 Mechanisms of wound healing in rats with streptozotocin-induced diabetes mellitus   Anna Gorbacheva, Russian Federation
P099 6-years results of the treatment of diabetic foot ulcers   Vadim Bregovskiy, Russian Federation
P100 Study of Diabetic Foot at Ain-Shams University Hospitals : Risk Categorization and Predictors.    Yara Eid, Egypt
P101 Recurrent ulcer versus single foot ulcer: is there any difference between patients and outcomes of the treatment?   Anastasia Demina, Russian Federation
P102 Patient and health care professional's perspectives on what is the most appropriate clinical outcome for patients at risk of reulceration.    katie Gray, United Kingdom
P104 The need for lower limb revascularization or amputation in diabetic foot infections: a cohort study   Tiago Santos, Portugal
P105 Reliability and usefulness of classic physical signs of lower extremity ischemia in general  diabetic population   Maria Bahteeva, Russian Federation
P106 Calf muscle electrostimulation effects vascular perfusion and walking capacity in type 2 diabetes patients with intermittent claudication   Alfred Gatt, Malta